Related Experiment Videos
[Thrombomodulin is a marker of microvascular, but not for macrovascular endothelial cell damage]
Unlabelled:
Plasma levels of thrombomodulin are increased in diseases associated with microangiopathia. The target of this study was to examine whether plasma thrombomodulin is also influenced by macroangiopathia. There was no variation of plasma thrombomodulin in a sample of 183 diabetic patients with or without peripheral arterio-occlusive disease of the lower limbs. In a second sample of 33 patients with peripheral arteriosclerosis of the lower limbs, without any indication of diabetes, plasma levels of thrombomodulin were not significantly increased compared to a control group. Since thrombomodulin is also found in thrombocytes, we analysed whether plasma thrombomodulin levels were influenced by platelet activation. Neither platelet activation after hyperthermal limb perfusion not the PGE1-treatment showed any effect on plasma thrombomodulin level.
Conclusion:
Thrombomodulin is a marker for microvascular but not for macrovascular endothelial cell damage.
Insights
Plasma thrombomodulin levels are elevated in microvascular diseases but not macrovascular conditions like peripheral arterio-occlusive disease. This study confirms thrombomodulin is a specific marker for microvascular endothelial damage, not macrovascular issues.
Area of Science:
- Biochemistry
- Vascular Biology
- Clinical Medicine
Context:
- Plasma thrombomodulin is an established biomarker for microvascular endothelial damage.
- Macrovascular diseases, such as peripheral arterio-occlusive disease, involve large blood vessels and their endothelial linings.
- The relationship between thrombomodulin and macrovascular pathology requires further elucidation.
Purpose:
- To investigate whether plasma thrombomodulin levels are influenced by macroangiopathia.
- To determine if peripheral arterio-occlusive disease affects plasma thrombomodulin.
- To assess the impact of platelet activation on plasma thrombomodulin levels.
Summary:
- A study involving 183 diabetic patients with or without peripheral arterio-occlusive disease showed no variation in plasma thrombomodulin.
- In a separate cohort of 33 patients with peripheral arteriosclerosis, plasma thrombomodulin levels were not significantly elevated compared to controls.
- Platelet activation, induced by hyperthermal limb perfusion or PGE1 treatment, did not alter plasma thrombomodulin levels.
Impact:
- Thrombomodulin serves as a specific indicator for microvascular endothelial cell damage.
- Plasma thrombomodulin is not a reliable marker for macrovascular endothelial cell damage.
- These findings refine the diagnostic utility of thrombomodulin in vascular diseases.